S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|ACADIA Pharmaceuticals Reports Second Quarter 2014 Financial Results|
|ACADIA Pharmaceuticals to Announce Second Quarter 2014 Financial Results on August 5, 2014|
|ACADIA Pharmaceuticals Receives FDA Breakthrough Therapy Designation for NUPLAZID™ (Pimavanserin) for Parkinson’s Disease Psychosis|
|ACADIA Pharmaceuticals Announces Appointment of Stephen Davis as Executive Vice President, Chief Financial Officer and Chief Business Officer|
|ACADIA Pharmaceuticals Announces Trade Name NUPLAZID™ for Pimavanserin|
|InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action|
|Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite|
|Lilly's Ixekizumab Superior to Etanercept and Placebo in Phase 3 Psoriasis Studies|
Click above to view more mutual fund data and stats for acad - ACADIA Pharmaceuticals Inc.